Rockwell Medical (NASDAQ:RMTI) Lowered to “Hold” Rating by StockNews.com

Rockwell Medical (NASDAQ:RMTI) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

Several other equities research analysts have also issued reports on RMTI. Rodman & Renshaw began coverage on shares of Rockwell Medical in a research report on Thursday, November 14th. They issued a “buy” rating and a $5.00 price objective for the company. HC Wainwright reiterated a “buy” rating and issued a $9.00 price target on shares of Rockwell Medical in a report on Wednesday, September 11th. Finally, RODMAN&RENSHAW raised Rockwell Medical to a “strong-buy” rating in a research report on Thursday, November 14th.

Rockwell Medical Stock Down 6.4 %

RMTI opened at $2.33 on Thursday. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $5.15. The firm has a 50 day moving average price of $3.63 and a 200 day moving average price of $2.64. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41. The company has a market cap of $75.30 million, a PE ratio of -46.60 and a beta of 1.50.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in RMTI. Vanguard Group Inc. lifted its holdings in Rockwell Medical by 4.0% in the 1st quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock worth $1,856,000 after buying an additional 43,302 shares in the last quarter. Armistice Capital LLC increased its position in shares of Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after acquiring an additional 592,000 shares during the last quarter. Renaissance Technologies LLC increased its position in shares of Rockwell Medical by 877.1% during the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after acquiring an additional 92,189 shares during the last quarter. Beacon Financial Advisory LLC acquired a new position in shares of Rockwell Medical in the third quarter worth about $98,000. Finally, Verus Capital Partners LLC purchased a new position in Rockwell Medical in the third quarter valued at about $51,000. 23.31% of the stock is currently owned by hedge funds and other institutional investors.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.